Accuray Inc

TCW Group’s warrant buy‑in of Accuray signals bullish confidence, hinting at future upside amid the company’s oncology expansion and potential dilution risks.

Accuray insider activity shows a strategic shift: executives sell vested RSUs for liquidity while keeping common shares, signaling confidence in a turnaround.